Compass Gold (PK) Stock Quote COGDF - Stock Price, News, Charts, Message Board, Trades

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
USOTC
Compass Gold Corporation (PK) (COGDF) Quote

Compass Gold Corporation (PK) (COGDF)

0.0798

0.00

( 0.00% )

Updated: 09:30:05

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Current Price

0.0798

Bid

0.011

Ask

0.0798

Volume

-

0.00 Day's Range 0.00

0.0004 52 Week Range 0.0798

Market Cap

Previous Close

0.0798

Open

-

Last Trade

Last Trade Time

-

Financial Volume

-

VWAP

-

Average Volume (3m)

3,200

Shares Outstanding

103,970,446

Dividend Yield

-

PE Ratio

-15.15

Earnings Per Share (EPS)

-0.01

Revenue

-

Net Profit

-684k

Sector

Miscellaneous Metal Ores,nec

Industry

Business Services, Nec

Website

www.compassgoldcorp.com

Headquarters

Toronto, Ontario, Can

Founded

1988

Compass Gold Corporation (PK) is listed in the Miscellaneous Metal Ores sector of the OTCMarkets with ticker COGDF. The last closing price for Compass Gold (PK) was $0.08. Over the last year, Compass Gold (PK) shares have traded in a share price range of $ 0.0004 to $ 0.0798.

Compass Gold (PK) currently has 103,970,446 shares outstanding. The market capitalization of Compass Gold (PK) is $8.30 million. Compass Gold (PK) has a price to earnings ratio (PE ratio) of -15.15.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.0009	1.14068441065	0.0789	0.0798	0.0789	3000	0.0798	CS
4	0.0688	625.454545455	0.011	0.0798	0.011	2750	0.04852727	CS
12	0.0794	19850	0.0004	0.0798	0.0004	3200	0.028725	CS
26	0.0174	27.8846153846	0.0624	0.0798	0.0004	4056	0.03915068	CS
52	0.0048	6.4	0.075	0.0798	0.0004	11550	0.063671	CS
156	-0.0602	-43	0.14	0.14599	0.0004	9384	0.07059183	CS
260	-0.1502	-65.3043478261	0.23	0.498302	0.0004	14475	0.24497478	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
COUVCorporate Universe Inc (CE)	$ 0.0402 (20,000.00%)	500
XCRPXcorporeal Inc (CE)	$ 0.0001 (9,900.00%)	122.49k
MJWLMajic Wheels Corp (CE)	$ 0.0001 (9,900.00%)	350.08k
NWPNNow Corp (PK)	$ 0.0001 (9,900.00%)	17.58M
MMEXMMEX Resources Corporation (PK)	$ 0.0001 (9,900.00%)	175.2k
ZLSSFZalatoris II Acquisition Corporation (CE)	$ 0.0011 (-99.99%)	1.39k
JUVAFJuva Life Inc (CE)	$ 0.000001 (-99.92%)	500
MLBEF5G Networks Ltd (PK)	$ 0.0001 (-99.89%)	318
KALOKallo Inc (CE)	$ 0.000001 (-99.67%)	2.39k
LSDIFLucy Scientific Discovery Inc (CE)	$ 0.0005 (-99.17%)	121
PLPLPlandai Biotechnology Inc (PK)	$ 0.0002 (0.00%)	128.69M
BIEIPremier Biomedical Inc (PK)	$ 0.0018 (34.33%)	125.84M
ASIIAccredited Solutions Inc (PK)	$ 0.0005 (0.00%)	121.49M
PSRUValiant Eagle Inc (PK)	$ 0.0001 (-33.33%)	114.17M
AAPJAAP Inc (PK)	$ 0.0004 (0.00%)	96.3M

mackwheaton

mackwheaton 5 minutes ago

Good info, thanks proto

I think the $250M shelf might be scaring some, historically offering invite share price drops. I suspect this one will be held for an acquisition or a facility build-out, so it should be more SP neutral (famous last words). The current SP is laughable, but bec

mick

mick 5 minutes ago

The latest sign of Intel's struggles and how it got here.

Elliott Management's increased stake in Southwest, and how the activist investor is planning on improving the airline.

Boeing's recent analyst downgrade, and why manufacturing issues might lead to financial ones

Tree

Tree 5 minutes ago

Is up the only way to go? :-D

DredLock

DredLock 5 minutes ago

Wow! Hate to stay on this topic but like I said my ex walked out on me 3 years ago and the initial pain was UNBEARABLE but since then the peace and stress free life I have now I WISH everybody can experience. I LOVE my life and new gained freedom. I totally understand what you deal with now. I can

Cake Eater

Cake Eater 6 minutes ago

ANDA (Abbreviated New Drug Application) approvals have several implications for market competition in the pharmaceutical industry:

Increase in Overall ANDA Approvals
The FDA has approved more generic drugs in recent years, particularly during the Generic Drug User Fee Amendment

fung_derf

fung_derf 6 minutes ago

Considering I'm diversified I'm just dandy. My accounts have been up as late.
Of course, if you took the time to actual look at my posts, I've been advising people to wait to buy SMCI in the low $300's, so not really sure who you think you're schooling? Go back and look at my board as I post

tw0122

tw0122 6 minutes ago

Nice call Glenn

Here Today

Here Today 6 minutes ago

No it wouldn’t. Posting audited financials showing real revenues in the $millions of dollars will be all it needs to Uplist. As of now, only revenues they have received were off of licensing fees and whatever little bit of online sales they have had. But now with real revenues about to start coming

ORCA

ORCA 6 minutes ago

WHO KNOWS.BUT LIKE I SAID IT IS VERY STRANGE THAT SELLING ALL OF SUDDEN STOPPED.BARBARA HAS NOT SOLD IN MORE THAN 5 WEEKS NOW.WHICH IS THE FIRST TIME IN YEARS.WHAT CHANGED???

tw0122

tw0122 6 minutes ago

I smart again lol

jammy32

jammy32 6 minutes ago

You’ve added no value

vlispxpert

vlispxpert 6 minutes ago

last gasps bro, watch & learn son

pos_stock_hoarder

pos_stock_hoarder 6 minutes ago

Not that anyone here doesn't know, but I just wanted to tip my hat to Jack Bruce.

And another tip to JPJ of Led Led Zeppelin!

gail

gail 6 minutes ago

weeeeee!!!!!! you find all the runners!

mick

mick 7 minutes ago

The company will wind down the R&D unit that works on light detection and ranging, or lidar, by the end of 2024, affecting about 100 employees. Mobileye employed a total of 3,700 people globally as of Dec. 30, 2023.

Operating expenses for the lidar R&D unit are expected to be about $6

jammy32

jammy32 7 minutes ago

Why do you care ? Do you own anything ? Seriously

ptcgolf

ptcgolf 7 minutes ago

Speculation to trade - a solid yes, to hold long term absolutely not (throwing your money away). Management clearly cares little about the retail investor, they will end up doing another RS (before the end of the first quarter next year in my opinion). Management will just issue compensatory share

Hosai

Hosai 7 minutes ago

Interesting though this trial only had 83 on drug and 78 on placebo vs the MRI finding for Anavex which had 165 on drug record a final MRI reading and 100 on placebo.
The effect size seems to be slightly smaller with the dosed group losing 1.2% of grey matter vs dosed group in Blarcamesine t

hotdawg

hotdawg 7 minutes ago

Nothing on financials till November.

stock1ace1

stock1ace1 7 minutes ago

Yes its rolling over busting green and ripping !

jjjjjjjj

jjjjjjjj 8 minutes ago

Good work. Good work. Good work. SET SELL HIGH your shares. MJNA is a good company. Best to us longs.

justhefax

justhefax 8 minutes ago

one issue is the statement in earlier release about all current mgt leaving.

Any new mgt will need to speak to issues prior to reverse such as Kona LLC sale amount among others.

TrendTrade2016

TrendTrade2016 8 minutes ago

AND TRAP...WATCH AND LEARN...SCAM!!!

SusieQutie

SusieQutie 9 minutes ago

It costs money to procure audits and file reports. Money they do not have. They are attempting to obtain more toxic financing, at your expense, in order to get current yet again and continue the scam. “Summer’s Almost Gone.”

Compass Gold (PK)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions